Leadercare
CLOSE X

UTI Healthcare Fund-Reg(G)

As on May-17-2022 change fund
145.46  up1.49 (1.04%)

fund objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2017-20182018-20192019-20202020-20212021-2022
NAV in Rs (as on 31-Mar-2022)82.2586.1480.12139.38157.00
Net Assets(Rs Crores) (as on 31-Mar-2022) 387.31 439.81 360.08 618.13 776.23
Scheme Returns(%)(Absolute)-8.883.28-7.1376.1912.06
B'mark Returns(%)(Absolute)-14.457.46-15.0279.0813.52
Category Rank53/6232/7316/7535/7550/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2021-202218.403.30-0.64-7.30
2020-202130.5824.119.54-2.01
2019-2020-7.94-1.668.97-5.72
2018-20190.317.90-5.642.55
2017-2018-5.81-2.5210.45-9.45
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...10.71 
Dr. Reddy's Laboratories Ltd.7.99 
Cipla Ltd.7.85 
Divi's Laboratories Ltd.5.25 
Fortis Healthcare Ltd.4.97 
Aurobindo Pharma Ltd.4.84 
Krishna Institute of Medical S...4.14 
Lupin Ltd.3.96 
Ipca Laboratories Ltd.3.70 
Biocon Ltd.3.70 

Category

Sector Funds

Launch Date

01-Aug-05

ISIN Code

INF789F01695

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

766.09

portfolio price to book value

5.66

investing style?

Mid Growth

fund manager?

V. Srivatsa,Kamal Gada

inception date (regular plan)

01-Aug-05

expense ratio (regular plan) %

2.16

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs79.05
Hospital & Healthcare Services17.56
Medical Equipment/Supplies/Accessories1.70

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005766.09-7.5122.1710.9513.6517.27
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,789.63-1.0827.49NANA20.64
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,270.01-1.6427.18NANA22.78
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,851.32-5.4424.2515.7516.9620.15
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,391.65-6.7323.90NANA17.00
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,763.30-7.2722.399.5515.4114.93
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015538.47-2.9822.3511.56NA7.46
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201967.07-6.9520.24NANA17.66
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019506.02-6.18NANANA20.08
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021174.80NANANANA-10.62
ENTRY LOAD / EXIT LOAD
Max Entry Load [%]
0.00
Entry Remark
Max Exit Load [%]
1.00
Exit Remark
1% on or before 30D, Nil after 30D
52 Week Highs & Lows
52 Week High
173.62
52 Week Low
142.51
portfolio characteristics
As on 30-Apr-2022
Average Maturity
N.A
Modified Duration
N.A
Yield to Maturity
N.A.
Portfolio Turnover Ratio
0.4 Times
ratios
Statistical Ratios
Standard Deviation [%]
17.4581
Semi Standard Deviation [%]
0.6393
Beta [%]
0.5455
Sharp Ratio [%]
-0.2448
R-Square [%]
0.6127
Expense Ratio [%]
2.1600
AVG Ratio [%]
0.0469
Other Ratios
Jenson Ratio [%]
-0.0568
Treynor Ratio [%]
-0.0682
Turnover Ratio [%]
40.0000
FAMA Ratio [%]
-0.0576
SORTINO Ratio [%]
0.0562
HEAD OFFICE Leader Care A-507/8 Navratna Corporate Park, Ashok Vatika Bopal-Ambli Road, Ahmedabad-380058
DISCLAIMER

Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objective of the Scheme will be achieved. Past performance of the Sponsor/AMC/Fund or that of any scheme of the Fund does not indicate the future performance of the Schemes of the Fund. Please read the Key Information Memorandum and the Offer Document carefully before investing.

  • INSURANCE DISCLAIMER - Insurance is a subject matter of solicitation
  • ARN Number - 11439
  • IRDAI Licence Number - AGQ0127782

Copyright © 2019Leader CareAll rights reserved

Designed, Developed & Content Powered by Accord Fintech Pvt. Ltd.